Recent Bills
- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
Committees
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means
W STRATEGIES, LLC is a registrant on 296 federal lobbying filings, 2023 to 2026, reporting $12.9M across them.
An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.
Clients
25 who it filed for, by filings.
| Client | Filings | Reported |
|---|---|---|
| ABBOTT LABORATORIES | 14 | $700K |
| ABBVIE INC. | 14 | $700K |
| ASTRAZENECA PHARMACEUTICALS LP | 14 | $1.1M |
| CALIFORNIA LIFE SCIENCES | 14 | $560K |
| DELFI DIAGNOSTICS | 14 | $510K |
| GILEAD SCIENCES, INC. | 14 | $840K |
| GLAXOSMITHKLINE | 14 | $560K |
| INCYTE CORPORATION | 14 | $840K |
| IPSEN BIOPHARMACEUTICALS, INC. | 14 | $280K |
| JUUL LABS INC | 14 | $700K |
| MEDTRONIC, INC. | 14 | $560K |
| MERCK & CO., INC. | 14 | $700K |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | 14 | $620K |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 14 | $840K |
| SANOFI U.S. SERVICES, INC. | 14 | $700K |
| UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA) | 14 | $420K |
| PHLOW CORP. | 13 | $560K |
| SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS | 12 | $600K |
| ALVEO TECHNOLOGIES | 9 | — |
| ELEVATEBIO | 6 | $170K |
| KARUNA THERAPEUTICS | 6 | $300K |
| MCKESSON CORPORATION | 6 | $120K |
| PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL | 5 | $140K |
| VIR BIOTECHNOLOGY, INC. | 4 | $180K |
| BRISTOL-MYERS SQUIBB COMPANY | 3 | $80K |
By year
Filings and what they reported, newest year first.
| Year | Filings | Income | Expenses |
|---|---|---|---|
| 2026 | 45 | $1.9M | — |
| 2025 | 86 | $3.7M | — |
| 2024 | 82 | $3.6M | — |
| 2023 | 83 | $3.7M | — |
Issues
The LDA issue codes the filings were filed under.
| Code | Issue | Filings |
|---|---|---|
HCR | Health Issues | 177 |
MMM | Medicare/Medicaid | 172 |
PHA | Pharmacy | 29 |
TOB | Tobacco | 14 |
TAX | Taxation/Internal Revenue Code | 12 |
MED | Medical/Disease Research/Clinical Labs | 11 |
Bills
The bills the filings name, by how many name them.
| Bill | Title | Filings |
|---|---|---|
| H.R. 5376 | Impacts and Outcomes for Health Career Training Act | 22 |
| H.R. 946 | ORPHAN Cures Act | 17 |
| H.R. 1 | An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | 12 |
| H.R. 1492 | To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi… | 11 |
| H.R. 1406 | Lung Cancer Screening and Prevention Act of 2025 | 6 |
| H.R. 2300 | To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and fo… | 5 |
| H.R. 1990 | American Innovation and R&D Competitiveness Act of 2025 | 2 |
Lobbyists
Named on the filings.
| Lobbyist | Clients | Filings |
|---|---|---|
| DARREN WILLCOX | 28 | 294 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.
| Client | Registrant | Period | Reported | Posted |
|---|---|---|---|---|
| UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA) | W STRATEGIES, LLC | 2026 second_quarter | $30K | Jul 20, 2026 |
| SANOFI U.S. SERVICES, INC. | W STRATEGIES, LLC | 2026 second_quarter | $50K | Jul 20, 2026 |
| PHLOW CORP. | W STRATEGIES, LLC | 2026 second_quarter | $50K | Jul 20, 2026 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | W STRATEGIES, LLC | 2026 second_quarter | $60K | Jul 20, 2026 |
| PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL | W STRATEGIES, LLC | 2026 second_quarter | $40K | Jul 20, 2026 |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | W STRATEGIES, LLC | 2026 second_quarter | $50K | Jul 20, 2026 |
| MERCK & CO., INC. | W STRATEGIES, LLC | 2026 second_quarter | $50K | Jul 20, 2026 |
| MEDTRONIC, INC. | W STRATEGIES, LLC | 2026 second_quarter | $40K | Jul 20, 2026 |
| JUUL LABS INC | W STRATEGIES, LLC | 2026 second_quarter | $60K | Jul 20, 2026 |
| IPSEN BIOPHARMACEUTICALS, INC. | W STRATEGIES, LLC | 2026 second_quarter | $20K | Jul 20, 2026 |
| INCYTE CORPORATION | W STRATEGIES, LLC | 2026 second_quarter | $60K | Jul 20, 2026 |
| GLAXOSMITHKLINE | W STRATEGIES, LLC | 2026 second_quarter | $40K | Jul 20, 2026 |
| GILEAD SCIENCES, INC. | W STRATEGIES, LLC | 2026 second_quarter | $60K | Jul 20, 2026 |
| EXELIXIS, INC. | W STRATEGIES, LLC | 2026 second_quarter | $60K | Jul 20, 2026 |
| DYNE THERAPEUTICS, INC. | W STRATEGIES, LLC | 2026 second_quarter | $40K | Jul 20, 2026 |
| DELFI DIAGNOSTICS | W STRATEGIES, LLC | 2026 second_quarter | $30K | Jul 20, 2026 |
| CALIFORNIA LIFE SCIENCES | W STRATEGIES, LLC | 2026 second_quarter | $40K | Jul 20, 2026 |
| BRISTOL-MYERS SQUIBB COMPANY | W STRATEGIES, LLC | 2026 second_quarter | $50K | Jul 20, 2026 |
| ASTRAZENECA PHARMACEUTICALS LP | W STRATEGIES, LLC | 2026 second_quarter | $80K | Jul 20, 2026 |
| ALVEO TECHNOLOGIES | W STRATEGIES, LLC | 2026 second_quarter | — | Jul 20, 2026 |
| ABBVIE INC. | W STRATEGIES, LLC | 2026 second_quarter | $50K | Jul 20, 2026 |
| ABBOTT LABORATORIES | W STRATEGIES, LLC | 2026 second_quarter | $50K | Jul 20, 2026 |
| EXELIXIS, INC. | W STRATEGIES, LLC | 2026 second_quarter | — | May 7, 2026 |
| SANOFI U.S. SERVICES, INC. | W STRATEGIES, LLC | 2026 first_quarter | $50K | Apr 20, 2026 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | W STRATEGIES, LLC | 2026 first_quarter | $60K | Apr 20, 2026 |